LUNAI BIOWORKS, INC. — Income Charts
13 years of history · ending 2023-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$-127K
Cost of Revenue
$5K
Gross Profit
$37K
R&D↑+66.7% +$2M
$4M
D&A↑+58.3% +$42K
$113K
Operating Income↓-250.8% -$28M
$-39M
EBITDA↓-252.1% -$28M
$-38M
Interest Expense↑+1349537.2% +$580K
$580K
Interest Income↑+166.4% +$76K
$122K
Other Income/Expense↑+92.3% +$7M
$-547K
Pretax Income↓-120.3% -$22M
$-40M
Tax Provision↑+100.0% +$112K
$34
Net Income↓-120.3% -$22M
$-40M
Gross Margin
87.7%
Operating Margin
30450.9%
Net Margin
31341.1%
Effective Tax Rate↓-1.7pts
-0.0%
DTA Valuation Allowance↑+2844.8% +$140M
$145M
NOL Carryforwards↑+3054.9% +$136M
$141M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
-34.0%
Operating Lease Cost
$322K
Revenue YoY Variation
-203.8%
Income YoY Variation↑+173.0pts
66.8%